StreetInsider.com News Articles

MedWell Ai, Inc Reports Q3 Revenues Of $618,676 And Provides Corporate Update

Wed, 06 May 2026 09:00:00 -0400

CLEARWATER, Fla., May 06, 2026 (GLOBE NEWSWIRE) -- via IBN -- MedWell Ai, Inc, (OTCQB:MWAI) ("Company") is a portfolio company, specializing in AI-driven solutions for B2B markets in pharmaceuticals, healthcare, and wellness sectors, is pleased to confirm the filing, of its Quarterly Report (Form 10-Q), for the financial period, ending on March 31, 2026.

Key Financial Highlights:

Increased Total Revenues:

For three months, ended March 31, 2026, Company had generated total revenues of $618,676 ($638,336 including deferred revenues) vs $281,318, for three months, ended March 31, 2025.
For nine months, ended March

MedWell Ai, Inc Reports Q3 Revenues Of $618,676 And Provides Corporate Update

Wed, 06 May 2026 09:00:00 -0400

Key Financial Highlights:

Increased Total Revenues:

For three months, ended March 31, 2026, Company had generated total revenues of $618,676 ($638,336 including deferred revenues) vs $281,318, for three months, ended March 31, 2025.
For nine months, ended March

MedWell Ai, Inc Reports Q3 Revenues Of $618,676 And Provides Corporate Update

Wed, 06 May 2026 09:00:00 -0400

Key Financial Highlights:

Increased Total Revenues:

For three months, ended March 31, 2026, Company had generated total revenues of $618,676 ($638,336 including deferred revenues) vs $281,318, for three months, ended March 31, 2025.
For nine months, ended March

MedWell Ai, Inc Reports Q3 Revenues Of $618,676 And Provides Corporate Update

Wed, 06 May 2026 09:00:00 -0400

Key Financial Highlights:

Increased Total Revenues:

For three months, ended March 31, 2026, Company had generated total revenues of $618,676 ($638,336 including deferred revenues) vs $281,318, for three months, ended March 31, 2025.
For nine months, ended March

Form 10-Q MedWellAI, Inc. For: Mar 31

Tue, 05 May 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260505/26434606.html

Form 10-Q MedWellAI, Inc. For: Mar 31

Tue, 05 May 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260505/26434606.html

Form 10-Q MedWellAI, Inc. For: Mar 31

Tue, 05 May 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260505/26434606.html

Form 8-K MedWellAI, Inc. For: Apr 16

Fri, 17 Apr 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260417/26330576.html

Form 8-K MedWellAI, Inc. For: Apr 16

Fri, 17 Apr 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260417/26330576.html

Form 8-K MedWellAI, Inc. For: Apr 16

Fri, 17 Apr 2026 16:04:00 -0400

si-local-file:///var/storage/secattach/20260417/26330576.html

Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc.

Wed, 08 Apr 2026 09:30:00 -0400

North Bergen, New Jersey--(Newsfile Corp. - April 8, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company" or "Apollo"), in conjunction with the final due diligence being reviewed by MedwellAI, Inc. (OTCQB: MWAI) to acquire Apollo and its subsidiaries including Evolutionary Biologics, Inc. ("Evo Bio"), (the "Transaction"), MWAI has reserved a Preferred Series B class of stock for the share exchanged and assumption of certain liabilities of Apollo. Negotiations are ongoing with certain secured creditors and debtholders of the Company that need to be resolved prior to closing the transaction.

CLEARWATER, Fla., Feb. 23, 2026 (GLOBE NEWSWIRE) -- via IBN -- MedWell Ai, Inc, (OTCQB:MWAI) ("Company") is a portfolio company, specializing in AI-driven solutions for B2B markets in pharmaceuticals, healthcare, and wellness, is pleased to confirm the filing, after the market close, of its Quarterly Report (Form 10-Q), for the financial period, ending on December 31, 2025.

The Company reported $548,315 in Revenue for its fiscal second quarter of 2025. This performance was result of a successful strategic shift toward building an AI-driven healthcare, pharmaceutical and biological wellness portfolio.

Key Financial Highlights:

MedWell Ai Reports Strong Q2 Revenues Of $548,315 And Provides Guidance For Full Year 2025 Exceeding $2,200,000

Mon, 23 Feb 2026 10:01:00 -0400

Key Financial Highlights:

MedWell Ai Reports Strong Q2 Revenues Of $548,315 And Provides Guidance For Full Year 2025 Exceeding $2,200,000

Mon, 23 Feb 2026 10:01:00 -0400

Key Financial Highlights:

MedWell Ai Reports Strong Q2 Revenues Of $548,315 And Provides Guidance For Full Year 2025 Exceeding $2,200,000

Mon, 23 Feb 2026 10:01:00 -0400

Key Financial Highlights:

Form NT 10-Q MedWellAI, Inc. For: Dec 31

Wed, 18 Feb 2026 12:51:00 -0400

si-local-file:///var/storage/secattach/20260218/26020383.html

Form NT 10-Q MedWellAI, Inc. For: Dec 31

Wed, 18 Feb 2026 12:51:00 -0400

si-local-file:///var/storage/secattach/20260218/26020383.html

Form NT 10-Q MedWellAI, Inc. For: Dec 31

Wed, 18 Feb 2026 12:51:00 -0400

si-local-file:///var/storage/secattach/20260218/26020383.html

MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System

Tue, 10 Feb 2026 10:08:00 -0400

CLEARWATER, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- via IBN – MedWell Ai, Inc ("Company") (OTCQB: MWAI) is pleased to announce the signing of a Letter of Intent (“LOI”) to create a vertically integrated health, wellness and longevity platform.

New MedWell Ai, Inc will be organized across three core divisions: (1) national pharma distribution and telemed platform, (2) nationwide portfolio of premium surgical and cosmetic centers and men’s healthcare franchise brand and (3) advanced biologics and product innovation group.

The Company will acquire, consolidate and operate the following divisions:

MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System

Tue, 10 Feb 2026 10:08:00 -0400

The Company will acquire, consolidate and operate the following divisions:

MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System

Tue, 10 Feb 2026 10:08:00 -0400

The Company will acquire, consolidate and operate the following divisions: